Catherine Shaffer Articles
Last 50 articles...
- What Biotech Investors Need to Know About Phase 2 Trials
- Biotech Investing 101: What Investors Need to Know About Phase 1 Trials
- Merck Launches Hail Mary Lung Cancer Trial
- Idera Pharmaceuticals, Inc. Bouncing on Phase 2 Success
- Overall Survival Will Be Critical for Endocyte's Vintafolide
- Is Idera's Sell-Off Premature?
- ThromboGenics Plays Long Game for Eye Disease
- Is Celldex's Loss Alexion's Gain?
- 3 Things to Know About Omeros Corporation
- What This FDA Decision Means for Amarin Investors